Enabling scalable final assembly for cartridge-based autoinjectors

Summary

As combination products become increasingly complex, manufacturers need production strategies that can efficiently bridge clinical validation and commercial supply while adapting to evolving market demand. Using the Reunite dual-chamber autoinjector and the AOU assembly platform as a case study, this article explores how SHL Medical and its subgroups, SHL Advantec and SHL Medical Assembly and Services, bring together device development, automation engineering, and final assembly through a concurrent design for manufacturing and assembly (DFMA) approach. It discusses how flexible automation architecture and scalable final assembly services help support manufacturing agility, quality, and long-term commercial growth for cartridge-based autoinjectors.

Key takeaways

• Concurrent DFMA approach aligning device design, automation, and final assembly
• Reunite case study from clinical validation to commercial manufacturing
• Early manufacturing integration supporting product quality at scale
• Modular AOU assembly platform for flexible production strategies
• Scalable automation from initial launch to high-volume manufacturing
• Multi-project compatibility across cartridge-based NIT autoinjectors
• Manufacturing agility to address evolving commercial demand
• Integrated automation and final assembly enabling resilient supply chains

Document details

• Format: Article
• Author/Spokesperson: 

  Christy Chen, Applications Engineering, SHL Advantec 

  Alberto Flores, Senior Manager, Manufacturing Sciences, SHL Medical Assembly and Services 

• Page count: 7 pages
• Estimated read time: ~14-15 minutes